Hikma Pharmaceuticals Plc Block listing Interim Review (1243V)
03 Abril 2023 - 3:27AM
UK Regulatory
TIDMHIK
RNS Number : 1243V
Hikma Pharmaceuticals Plc
03 April 2023
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 3 April 2023
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
-------------------------------------------------------------
Period of return From: 1 October 2022 To: 31 March 2023
------------------------------- ------ --------------------
Balance of unallotted securities under scheme(s) from SOP: 792,700 Ordinary Shares of 10 pence
previous return:
-------------------------------------------------------------
Plus: The amount by which the block scheme(s) has been SOP: 0 Ordinary Shares of 10 pence
increased since the date of the last
return (if any increase has been applied for):
-------------------------------------------------------------
Less: Number of securities issued/allotted under SOP: 0 Ordinary Shares of 10 pence
scheme(s) during period (see LR3.5.7G):
-------------------------------------------------------------
Equals: Balance under scheme(s) not yet SOP: 792,700 Ordinary Shares of 10 pence
issued/allotted at end of period:
-------------------------------------------------------------
The Hikma Pharmaceuticals plc 2004 Stock Option Plan has expired. No further shares may be
issued under the block listing and no further block listing returns will be made in respect
of this expired Plan; therefore, the block listing is hereby cancelled. In accordance with
LR3.5.6R, a final block listing return in respect of this block listing is set out above in
the prescribed form.
Name of contact: Hussein Arkhagha
Telephone number of contact: +44(0)20 7399 2760
-------------------
Block Listing Six Monthly Return
Date: 3 April 2023
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")
---------------------------------------------------------------------
Period of return From: 1 October 2022 To: 31 March 2023
------------------------------------ ------ -----------------------
Balance of unallotted securities under LTIP: 57,502 Ordinary Shares of 10 pence
scheme(s) from previous return:
---------------------------------------------------------------------
Plus: The amount by which the block scheme(s) LTIP: 0 Ordinary Shares of 10 pence
has been increased since the date of the last
return (if any increase has been applied for):
---------------------------------------------------------------------
Less: Number of securities issued/allotted LTIP: 0 Ordinary Shares of 10 pence
under scheme(s) during period (see LR3.5.7G):
---------------------------------------------------------------------
Equals: Balance under scheme(s) not yet LTIP: 57,502 Ordinary Shares of 10 pence
issued/allotted at end of period:
---------------------------------------------------------------------
The Hikma Pharmaceuticals plc 2005 Long-Term Incentive Plan has expired. No further shares
may be issued under the block listing and no further block listing returns will be made in
respect of this expired Plan; therefore, the block listing is hereby cancelled. In accordance
with LR3.5.6R, a final block listing return in respect of this block listing is set out above
in the prescribed form.
Name of contact: Hussein Arkhagha
Telephone number of contact: +44(0)20 7399 2760
-------------------
Block Listing Six Monthly Return
Date: 3 April 2023
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("2009 MIP")
--------------------------------------------------------------------------
Period of return From: 1 October 2022 To: 31 March 2023
-------------------------------------- ------- -------------------------
Balance of unallotted securities under 2009 MIP: 0 Ordinary Shares of 10 pence
scheme(s) from previous return:
--------------------------------------------------------------------------
Plus: The amount by which the block 2009 MIP: 0 Ordinary Shares of 10 pence
scheme(s) has been increased since the
date of the last
return (if any increase has been applied
for):
--------------------------------------------------------------------------
Less: Number of securities 2009 MIP: 0 Ordinary Shares of 10 pence
issued/allotted under scheme(s) during
period (see LR3.5.7G):
--------------------------------------------------------------------------
Equals: Balance under scheme(s) not yet 2009 MIP: 0 Ordinary Shares of 10 pence
issued/allotted at end of period:
--------------------------------------------------------------------------
The Hikma Pharmaceuticals plc 2009 Management Incentive Plan has expired. No further shares
may be issued under the block listing and no further block listing returns will be made in
respect of this expired Plan; therefore, the block listing is hereby cancelled. In accordance
with LR3.5.6R, a final block listing return in respect of this block listing is set out above
in the prescribed form.
Name of contact: Hussein Arkhagha
Telephone number of contact: +44(0)20 7399 2760
-------------------
Block Listing Six Monthly Return
Date: 3 April 2023
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP") and Hikma
Pharmaceuticals
PLC 2014 Executive Incentive Plan ("EIP") (together "the Plans")
----------------------------------------------------------------------------------
Period of return From: 1 October 2022 To: 31 March 2023
---------------------------------- ---------- ----------------------------------
Balance of unallotted securities 2018 MIP: 414,112 Ordinary Shares of 10 pence
under scheme(s) from previous EIP: 354,962 Ordinary Shares of 10 pence
return:
----------------------------------------------------------------------------------
Plus: The amount by which the The Plans: 1,200,000 Ordinary Shares of 10 pence
block scheme(s) has been
increased since the date of the
last
return (if any increase has been
applied for):
----------------------------------------------------------------------------------
Less: Number of securities 2018 MIP: 294,737 Ordinary Shares of 10 pence
issued/allotted under scheme(s) EIP: 176,424 Ordinary Shares of 10 pence
during period (see LR3.5.7G):
----------------------------------------------------------------------------------
Equals: Balance under scheme(s) The Plans: 1,497,913 Ordinary Shares of 10 pence
not yet issued/allotted at end of
period:
----------------------------------------------------------------------------------
Name of contact: Hussein Arkhagha
Telephone number of contact: +44(0)20 7399 2760
-------------------
LEI: 549300BNS685UXH4JI75
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLRUPUAPCUPWURW
(END) Dow Jones Newswires
April 03, 2023 04:27 ET (08:27 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
